NEW & HOT

Israeli Airstrike in Beirut's Southern Suburbs Kills Top Hezbollah Commander Ibrahim Aqil Qualcomm Reaches Out to Intel on Potential Mega-Takeover in Unprecedented Semiconductor Shakeup Constellation Energy to Restart Three Mile Island Nuclear Plant in Landmark 20-Year Microsoft AI Clean Power Deal Nike Announces Major Leadership Shakeup with Longtime Veteran Elliott Hill Replacing John Donahoe as CEO Wall Street Surges to Record Highs as S&P 500 Tops 5,700 Following Federal Reserve Rate Cut US House Defeats Speaker Johnson's Six-Month Stopgap Spending Bill Tied to SAVE Act Shohei Ohtani Achieves Historic 50-50 Milestone with 3-Homer, 10-RBI Masterpiece Massive Explosions at Toropets Munitions Depot in Tver Trigger Seismic Tremors Israeli Airstrike in Beirut's Southern Suburbs Kills Top Hezbollah Commander Ibrahim Aqil Qualcomm Reaches Out to Intel on Potential Mega-Takeover in Unprecedented Semiconductor Shakeup Constellation Energy to Restart Three Mile Island Nuclear Plant in Landmark 20-Year Microsoft AI Clean Power Deal Nike Announces Major Leadership Shakeup with Longtime Veteran Elliott Hill Replacing John Donahoe as CEO Wall Street Surges to Record Highs as S&P 500 Tops 5,700 Following Federal Reserve Rate Cut US House Defeats Speaker Johnson's Six-Month Stopgap Spending Bill Tied to SAVE Act Shohei Ohtani Achieves Historic 50-50 Milestone with 3-Homer, 10-RBI Masterpiece Massive Explosions at Toropets Munitions Depot in Tver Trigger Seismic Tremors

Topic

#Miplyffa

Microscope and pharmacological test tubes in advanced medical laboratory

health

FDA Approves Miplyffa as the First Medical Treatment for Rare Fatal Niemann-Pick Disease Type C

The FDA has granted historic approval to Miplyffa (arimoclomol), providing the first-ever pharmacological therapy for Niemann-Pick disease type C, an ultra-rare neurodegenerative disorder.

Jerry Vasoya ·20 Sep 2026 ·4 min read